Metformin alleviates allergic airway inflammation and increases Treg cells in obese asthma
Obesity increases the morbidity and severity of asthma, with poor sensitivity to corticosteroid treatment. Metformin has potential effects on improving asthma airway inflammation. Regulatory T cells (Tregs) play a key role in suppressing the immunoreaction to allergens. We built an obese asthmatic m...
Saved in:
| Published in: | Journal of cellular and molecular medicine Vol. 25; no. 4; pp. 2279 - 2284 |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
John Wiley & Sons, Inc
01.02.2021
John Wiley and Sons Inc |
| Subjects: | |
| ISSN: | 1582-1838, 1582-4934, 1582-4934 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Obesity increases the morbidity and severity of asthma, with poor sensitivity to corticosteroid treatment. Metformin has potential effects on improving asthma airway inflammation. Regulatory T cells (Tregs) play a key role in suppressing the immunoreaction to allergens. We built an obese asthmatic mouse model by administering a high‐fat diet (HFD) and ovalbumin (OVA) sensitization, with daily metformin treatment. We measured the body weight and airway inflammatory status by histological analysis, qRT‐PCR, and ELISA. The percentage of Tregs was measured by flow cytometry. Obese asthmatic mice displayed more severe airway inflammation and more significant changes in inflammatory cytokines. Metformin reversed the obese situation and alleviated the airway inflammation and remodelling with increased Tregs and related transcript factors. The anti‐inflammatory function of metformin may be mediated by increasing Tregs. |
|---|---|
| Bibliography: | Funding information This study was supported by National Nature Science Foundation of China (No.81670022, 81803636 and 8170010835), Nature Science Foundation of Guangdong Province (No.2017A030313822 and 2018A0303130329), Guangzhou Science and Technology Program Key Project (No.201704020123 and 202008040003) and Guangdong Key Technology R & D Program for Controlling 2019 n‐Cov (No.2020B111105001). ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Yimin Guo and Jianting Shi contributed equally to this manuscript. |
| ISSN: | 1582-1838 1582-4934 1582-4934 |
| DOI: | 10.1111/jcmm.16269 |